FDA Investigator: Mary T. Carden
- Mary T. Carden first started conducting FDA inspections in 2000, with the last inspection in 2009. Over that time, Mary T. Carden has conducted 34 inspections at 30 companies across 32 sites.
Get Mary Carden's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Transplant Resource Of Center of Maryland, Baltimore | 2009
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Windsor Quality Foods Co, Los Angeles | 2009
Out-of-stock
Mary T. Carden
Foods & Cosmetic Form 483
FDA 483 LifeNet Health, Virginia Beach | 2008
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Washington Hospital Center, Washington | 2007
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Rainbow Flag Health Services & Sperm Bank, Alameda | 2006
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 California Medical Facility Transfusion Service, Vacaville | 2006
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 American National Red Cross (The), West Henrietta | 2005
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 The American National Red Cross National Testing Laboratory, Charlotte | 2004
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Stanford Medical School Blood Center, Palo Alto | 2004
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 American National Red Cross, (The), Nat'l Testing Laboratory, San Diego | 2004
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Blood Systems Inc, Las Vegas | 2003
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Hawaii Organ Procurement Organization, Honolulu | 2003
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 American Red Cross Natl Hq, Washington | 2002
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Children's Hospital Boston, Boston | 2002
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Dana-farber Cancer Institute, Blood Donor Center, Boston | 2002
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 Organon Teknika B.V. - bioMerieux, BV, Boxtel | 2001
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 American National Red Cross (The), Salt Lake City | 2001
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 American Red Cross Natl Hq, Washington | 2000
Out-of-stock
Mary T. Carden
Biologic Form 483
FDA 483 American National Red Cross (The), Williamsville | 2000
Out-of-stock
Mary T. Carden
Biologic Form 483
Co-Investigators (22)
- Sarah A. Hassas, FDA Investigator
- Kyson X. Chou, FDA Investigator
- Wilfred A. Darang, FDA Investigator
- Gail L. Katz, FDA Investigator
- Linda S. Mattingly, FDA Investigator
- Brian S. Lynch, FDA Investigator
- Traci M. Armand, FDA Investigator
- Shelley H. Beausoleil, FDA Investigator
- Roger D. Gawne, FDA Investigator
- Deborah Kleinfeld, FDA Investigator
- Linda M. Sacco, FDA Investigator
- Eileen J. Bannerman, FDA Investigator
- Richard L. Garcia, FDA Investigator
- Paula J. Bretz, FDA Investigator
- Laverne Puckett, FDA Investigator
- Mary E. Wilkerson-Brinsko, FDA Investigator
- Sarah M. Forney, FDA Investigator
- Helen B. Ricalde, FDA Investigator
- Kelly D. Moore, FDA Investigator
- Deborah S. Hammond, FDA Investigator
- Tammy S. Notto, FDA Investigator
- Patricia A. Clark, FDA Investigator